Clinical Trial Update: Contribution of an Antiviral Drug (Valaciclovir) in the Treatment of Generalized Periodontitis (Stage III or IV and Grade A, B or C): Prospective, Randomized and Double Blind Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind trial evaluating the contribution of valaciclovir in treating generalized chronic periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Periodontitis
• Periodontitis

Drugs mentioned

• Valaciclovir (valaciclovir)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Periodontitis Chronic Generalized Severe | Phase 3 | Status: RECRUITING